1. Home
  2. BTGO vs CDNA Comparison

BTGO vs CDNA Comparison

Compare BTGO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTGO

BitGo Holdings Inc. Class A Common Stock

N/A

Current Price

$10.37

Market Cap

961.8M

Sector

Finance

ML Signal

N/A

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$22.52

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTGO
CDNA
Founded
2013
1998
Country
United States
United States
Employees
603
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
961.8M
1.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
BTGO
CDNA
Price
$10.37
$22.52
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$14.83
$27.33
AVG Volume (30 Days)
511.3K
557.8K
Earning Date
05-26-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,324,000.00
Revenue This Year
N/A
$16.01
Revenue Next Year
$34.97
$11.31
P/E Ratio
$10.81
N/A
Revenue Growth
N/A
18.93
52 Week Low
$7.25
$10.96
52 Week High
$15.30
$21.49

Technical Indicators

Market Signals
Indicator
BTGO
CDNA
Relative Strength Index (RSI) 57.93 71.47
Support Level $9.82 $16.63
Resistance Level $10.59 N/A
Average True Range (ATR) 0.74 1.13
MACD 0.32 0.38
Stochastic Oscillator 91.30 95.45

Price Performance

Historical Comparison
BTGO
CDNA

About BTGO BitGo Holdings Inc. Class A Common Stock

BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: